Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2026-02-27 @ 4:06 PM
Study NCT ID:
NCT02900560
Status:
TERMINATED
Last Update Posted:
2022-06-10
First Post:
2016-09-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer
Sponsor:
Translational Research in Oncology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12-20
Start Date Type:
ACTUAL
Primary Completion Date:
2021-05-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-05-27
Completion Date Type:
ACTUAL
First Submit Date:
2016-09-01
First Submit QC Date:
None
Study First Post Date:
2016-09-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-04-26
Results First Submit QC Date:
None
Results First Post Date:
2022-06-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-17
Last Update Post Date:
2022-06-10
Last Update Post Date Type:
ACTUAL